Marie Thibault
Stock Analyst at BTIG
(3.01)
# 1,268
Out of 4,479 analysts
64
Total ratings
49.12%
Success rate
8.15%
Average return
Main Sectors:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XAIR Beyond Air | Downgrades: Neutral | n/a | $0.64 | - | 2 | Jun 25, 2024 | |
| MASI Masimo | Maintains: Buy | $145 → $166 | $116.40 | +42.61% | 2 | Mar 25, 2024 | |
| BSX Boston Scientific | Reiterates: Buy | $64 | $76.41 | -16.24% | 5 | Dec 29, 2023 | |
| VERO Venus Concept | Downgrades: Neutral | n/a | $0.72 | - | 3 | Oct 6, 2023 | |
| DCTH Delcath Systems | Maintains: Buy | $19 → $20 | $8.26 | +142.13% | 2 | Aug 16, 2023 | |
| DXCM DexCom | Maintains: Buy | $134 → $150 | $112.17 | +33.73% | 6 | Jun 26, 2023 | |
| IRTC iRhythm Technologies | Maintains: Buy | $165 → $140 | $106.45 | +31.52% | 7 | Jun 8, 2023 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $100 → $105 | $43.34 | +142.27% | 6 | Apr 17, 2023 | |
| ICAD iCAD, Inc. | Maintains: Buy | $4 → $3 | $1.27 | +137.15% | 3 | Mar 29, 2023 | |
| ATRC AtriCure | Maintains: Buy | $65 → $55 | $22.50 | +144.44% | 3 | Feb 22, 2023 | |
| ABT Abbott Laboratories | Maintains: Buy | $120 → $125 | $103.20 | +21.12% | 10 | Jan 26, 2023 | |
| NARI Inari Medical | Maintains: Buy | $100 → $97 | $50.19 | +93.27% | 3 | Oct 17, 2022 | |
| EMBC Embecta | Initiates: Neutral | n/a | $12.15 | - | 1 | Sep 8, 2022 | |
| VAPO Vapotherm | Downgrades: Neutral | n/a | $2.11 | - | 2 | Aug 4, 2022 | |
| PODD Insulet | Maintains: Buy | $310 → $250 | $196.16 | +27.45% | 1 | Jun 24, 2022 | |
| AFIB Acutus Medical | Maintains: Buy | $2 → $1.5 | $0.03 | +4,738.71% | 3 | Jun 24, 2022 | |
| ARAY Accuray | Maintains: Buy | $9 → $7 | $1.76 | +297.73% | 1 | Jun 24, 2022 | |
| STIM Neuronetics | Downgrades: Neutral | n/a | $1.75 | - | 2 | Oct 13, 2021 | |
| SENS Senseonics Holdings | Downgrades: Neutral | n/a | $0.40 | - | 1 | Jan 21, 2021 | |
| SITM SiTime | Maintains: Buy | n/a | $122.53 | - | 1 | Apr 9, 2020 |
Beyond Air
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Masimo
Mar 25, 2024
Maintains: Buy
Price Target: $145 → $166
Current: $116.40
Upside: +42.61%
Boston Scientific
Dec 29, 2023
Reiterates: Buy
Price Target: $64
Current: $76.41
Upside: -16.24%
Venus Concept
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.72
Upside: -
Delcath Systems
Aug 16, 2023
Maintains: Buy
Price Target: $19 → $20
Current: $8.26
Upside: +142.13%
DexCom
Jun 26, 2023
Maintains: Buy
Price Target: $134 → $150
Current: $112.17
Upside: +33.73%
iRhythm Technologies
Jun 8, 2023
Maintains: Buy
Price Target: $165 → $140
Current: $106.45
Upside: +31.52%
Establishment Labs Holdings
Apr 17, 2023
Maintains: Buy
Price Target: $100 → $105
Current: $43.34
Upside: +142.27%
iCAD, Inc.
Mar 29, 2023
Maintains: Buy
Price Target: $4 → $3
Current: $1.27
Upside: +137.15%
AtriCure
Feb 22, 2023
Maintains: Buy
Price Target: $65 → $55
Current: $22.50
Upside: +144.44%
Abbott Laboratories
Jan 26, 2023
Maintains: Buy
Price Target: $120 → $125
Current: $103.20
Upside: +21.12%
Inari Medical
Oct 17, 2022
Maintains: Buy
Price Target: $100 → $97
Current: $50.19
Upside: +93.27%
Embecta
Sep 8, 2022
Initiates: Neutral
Price Target: n/a
Current: $12.15
Upside: -
Vapotherm
Aug 4, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.11
Upside: -
Insulet
Jun 24, 2022
Maintains: Buy
Price Target: $310 → $250
Current: $196.16
Upside: +27.45%
Acutus Medical
Jun 24, 2022
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.03
Upside: +4,738.71%
Accuray
Jun 24, 2022
Maintains: Buy
Price Target: $9 → $7
Current: $1.76
Upside: +297.73%
Neuronetics
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.75
Upside: -
Senseonics Holdings
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
SiTime
Apr 9, 2020
Maintains: Buy
Price Target: n/a
Current: $122.53
Upside: -